Patents Assigned to Roche Sequencing Solutions, Inc.
  • Patent number: 11953494
    Abstract: A nanopore-based sequencing system includes a plurality of nanopore-based sequencing chips. Each of the nanopore-based sequencing chips comprises a plurality of nanopore sensors. The system comprises at least one flow cell coupled to at least one of the plurality of nanopore-based sequencing chips, wherein the flow cell coupled to the at least one of the plurality of nanopore-based sequencing chips comprises one or more fluidic flow channels that allow a fluid external to the system to flow on top of the nanopore-based sequencing chip and out of the system. The system further comprises a printed circuit board electrically connected to the plurality of nanopore-based sequencing chips.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: April 9, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Yuri Mitnick, Xu Ouyang, Janusz B. Wojtowicz
  • Patent number: 11946099
    Abstract: The invention comprises a method of amplifying nucleic acids by primer extension with reduced formation of primer-primer byproducts.
    Type: Grant
    Filed: February 23, 2021
    Date of Patent: April 2, 2024
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventor: Brian Godwin
  • Patent number: 11939632
    Abstract: Embodiments may include a nucleic acid molecule system. The system may include a nucleic acid polymerase attached to a tether compound. The polymerase may be configured to elongate a nascent strand. The system may also include a nucleotide attached to a label compound. The label compound may include a moiety. The system may further include a transistor in electrical communication with a power supply. The polymer may be attached to the transistor. In addition, the system may include a meter device configured to measure an electrical characteristic of the transistor from the moiety after the label compound is cleaved from the nucleotide by the nucleic acid polymerase.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: March 26, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventor: Yann Astier
  • Patent number: 11939624
    Abstract: A method of barcoding is provided. The method comprises performing a ligation assay on target nucleic acid molecules that are in or on cells or cell organelles to produce ligation products and adding cell-origination barcodes onto the ligation products or complements thereof by a split-pool barcoding process.
    Type: Grant
    Filed: October 12, 2023
    Date of Patent: March 26, 2024
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventor: Garry P. Nolan
  • Patent number: 11932903
    Abstract: A kit for split-pool barcoding is provided. The kit comprises: a binding agent that binds to a target molecule that is in or on cells or cell organelles and at least two sets of assayable polymer subunit (APS) oligonucleotides. In the kit each set comprises at least 10 unique APS oligonucleotides, the APS oligonucleotides in a set each comprise a sequence that distinguishes the APS oligonucleotides from one another, and the APS oligonucleotides from different sets are configured to link together in an ordered fashion to form all or part of a cell or organelle origination barcode.
    Type: Grant
    Filed: August 11, 2023
    Date of Patent: March 19, 2024
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventor: Garry P. Nolan
  • Patent number: 11932902
    Abstract: A method for adding cell origination barcodes onto beads is provided. The method comprises: splitting a pool of beads into a plurality of reaction volumes, appending pre-made oligonucleotides onto the beads in the reaction volumes, wherein at least some of the reaction volumes each receive an oligonucleotide that contains a sequence that is different from the other oligonucleotides added to the reaction volumes, pooling the beads and repeating the splitting, appending and pooling steps one or more times to produce a pool of beads that comprise the cell origination barcodes. In the one or more repeats the oligonucleotides that are appended are added to previously appended oligonucleotides to form the cell origination barcodes.
    Type: Grant
    Filed: August 11, 2023
    Date of Patent: March 19, 2024
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventor: Garry P. Nolan
  • Patent number: 11926864
    Abstract: A method of barcoding is provided. The method comprises: providing a population of fixed cells or cell organelles in a first reaction volume, hybridizing oligonucleotide probes to target molecules that are in or on the cells or cell organelles in the first reaction volume, splitting the population of cells or cell organelles into a plurality of second reactions volumes, wherein at least some of the second reaction volumes receive a single fixed cell or cell organelle from the population of fixed cells or fixed cell organelles, and adding cell-specific nucleic acid barcodes onto: the oligonucleotide probes, ligation products comprising the oligonucleotide probes, or complements of the oligonucleotide probes or ligation products, in the plurality of second reaction volumes.
    Type: Grant
    Filed: October 12, 2023
    Date of Patent: March 12, 2024
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventor: Garry P. Nolan
  • Patent number: 11929147
    Abstract: Described herein are methods for identifying quasispecies of genomes by clustering sequence reads for samples including the genomes based on the similarities of the sequence reads.
    Type: Grant
    Filed: September 12, 2018
    Date of Patent: March 12, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Darya Filippova, Khai Luong, Garima Kushwaha
  • Patent number: 11920184
    Abstract: Methods and related products are disclosed that improve the probability of interaction between a target molecule and a nanopore by capturing the target molecule on a surface comprising the nanopore. The captured target molecule, the nanopore, or both, are able to move relative to each other along the surface. When the leader of the target molecule is in proximity with the nanopore, interaction of the target portion of the target molecule with the nanopore occurs, thereby permitting sensing of the target portion. Confining the target molecule and nanopore in this manner leads to significantly enhanced interaction with the nanopore.
    Type: Grant
    Filed: October 15, 2020
    Date of Patent: March 5, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Mark Stamatios Kokoris, Robert N. McRuer
  • Patent number: 11913062
    Abstract: Present disclosure provides a method including isolating DNA from a source, thereby providing a composition including the isolated DNA. The isolated DNA has at least first and second target regions, where the length of the second target region is greater than the length of the first target region. The method further includes quantifying a total mass of the isolated DNA, quantifying a first quantification cycle (Cq) of the first target region and a second Cq of the second target region, and calculating a Q-ratio for the isolated DNA by dividing the second Cq by the first Cq. The method further includes determining a value for a quality-mass constant (kQm), estimating a required input mass by dividing kQm by the Q-ratio, and preparing the isolated DNA for sequencing if the total mass of the isolated DNA in the composition is equal or greater than the required input mass.
    Type: Grant
    Filed: November 18, 2019
    Date of Patent: February 27, 2024
    Assignees: Roche Sequencing Solutions, Inc., Signature Diagnostics GmbH
    Inventors: Victoria Constandse, Daniel Klass, Alexander Lovejoy, Melissa Loyzer, Bronwen Miller, Bernd Hinzmann, Sophie Beckert
  • Patent number: 11898204
    Abstract: The invention is a novel method of separately sequencing each strand of a nucleic acid involving the use of an adaptor comprising a strand cleavage site or a strand synthesis termination site. The adaptor may also be self-priming at the strand cleavage site.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: February 13, 2024
    Assignees: Roche Sequencing Solutions, Inc., KAPA Biosystems, Inc.
    Inventors: Aruna Arcot, Daleen Badenhorst, Rui Chen, Toummy Guettouche, Ashley Hayes, Jenny A. Johnson, Severine Margeridon, Martin Ranik, Persis Wadia, Alexandra Hui Wang
  • Patent number: 11892444
    Abstract: Improved multi-cell nanopore-based sequencing chips and methods can employ formation, characterization, calibration, and/or normalization techniques. For example, various methods may include one or more steps of performing physical checks of cell circuitry, forming and characterizing a lipid layer on the cells, performing a zero point calibration of the cells, forming and characterizing nanopores on the lipid layers of each cell, performing a sequencing operation to accumulate sequencing signals from the cells, normalizing those sequencing signals, and determining bases based on the normalized sequencing signals.
    Type: Grant
    Filed: October 21, 2020
    Date of Patent: February 6, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Morgan Mager, John Mannion
  • Patent number: 11891661
    Abstract: A method of detecting a lipid bilayer formed in a cell of a nanopore based sequencing chip is disclosed. An integrating capacitor is coupled with a lipid membrane, wherein the lipid membrane is between a working electrode and a counter electrode. An alternating current (AC) voltage is applied to the counter electrode. A voltage across the integrating capacitor is periodically sampled by an analog-to-digital converter (ADC). A change in the sampled voltage across the integrating capacitor in response to a change in the AC voltage is determined. Whether the lipid membrane comprises a lipid bilayer is detected based on the determined change in the sampled voltage across the integrating capacitor in response to the change in the AC voltage.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: February 6, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Kevin Aliado, Roger J. A. Chen, Jing Luo, William Nielsen, Kyle Umeda, Ashraf Wahba
  • Patent number: 11884024
    Abstract: Techniques for forming a nanopore in a lipid bilayer are described herein. In one example, an agitation stimulus level such as an electrical agitation stimulus is applied to a lipid bilayer wherein the agitation stimulus level tends to facilitate the formation of nanopores in the lipid bilayer. In some embodiments, a change in an electrical property of the lipid bilayer resulting from the formation of the nanopore in the lipid bilayer is detected, and a nanopore has formed in the lipid bilayer is determined based on the detected change in the lipid bilayer electrical property.
    Type: Grant
    Filed: May 18, 2021
    Date of Patent: January 30, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Roger J. A. Chen, Randy Davis
  • Publication number: 20240010688
    Abstract: The present disclosure provides variant OmpG polypeptides, compositions comprising the OmpG variant polypeptides, and methods for using the variant OmpG polypeptides as nanopores for determining the sequence of single stranded nucleic acids. The variant OmpG nanopores reduce the ionic current noise versus the parental OmpG polypeptide from which they are derived and thereby enable sequencing of polynucleotides with single nucleotide resolution. The reduced ionic current noise also provides for the use of these OmpG nanopore variants in other single molecule sensing applications, e.g., protein sequencing.
    Type: Application
    Filed: August 15, 2023
    Publication date: January 11, 2024
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Cynthia CECH, Tim CRAIG, Christos TZITZILONIS, Alexander Yang, Liv JENSEN, Charlotte YANG, Corissa HARRIS, Matthew DIPIETRO, Dhruti DALAL
  • Patent number: 11866464
    Abstract: The present disclosure relates to relates methods and associated compositions that provide fast, efficient site-selective conjugation of a protein, such as the pore-forming protein ?-hemolysin, to a biomolecule, such as a DNA polymerase, and the use of such site-selective protein-biomolecule conjugates in nanopore devices and methods.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: January 9, 2024
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Dmitriy Gremyachinskiy, Christos Tzitzilonis
  • Publication number: 20240002928
    Abstract: Disclosed herein are embodiments of single-molecule array sequencing (SMAS) devices and systems. Each sensor of an array of sensors of the SMAS device is capable of detecting labels attached to nucleotides incorporated into a single nucleic acid strand bound to a respective binding site. Each sensor can detect a single label (e.g., fluorescent, magnetic, organometallic, charged molecule, etc.) attached to the incorporated nucleotide. Also disclosed are methods of using SMAS devices and systems for highly-scalable nucleic acid (e.g., DNA) sequencing based on sequencing by synthesis (SBS) of multiple instances of clonally amplified DNA immobilized on such SMAS devices. Also disclosed are error correction methods that mitigate errors (e.g., errant label detections or non-detections) made in sequencing individual nucleic acid strands.
    Type: Application
    Filed: April 21, 2021
    Publication date: January 4, 2024
    Applicants: Roche Sequencing Solutions, Inc., Western Digital Technologies, Inc.
    Inventors: Juraj TOPOLANCIK, Patrick BRAGANCA, Yann ASTIER, Sri PALADUGU
  • Patent number: 11859240
    Abstract: The invention provides methods, compositions, kits and devices for the detection of target molecules. In some embodiments, the invention allows for multiplexed target molecule detection.
    Type: Grant
    Filed: January 26, 2023
    Date of Patent: January 2, 2024
    Assignee: ROCHE SEQUENCING SOLUTIONS, INC.
    Inventor: Garry P. Nolan
  • Publication number: 20230416813
    Abstract: This disclosure provides a biochip comprising a plurality of wells. The biochip includes a membrane that is disposed in or adjacent to an individual well of the plurality of wells. The membrane comprises a nanopore, and the individual well comprises an electrode that detects a signal upon ionic flow through the pore in response to a species passing through or adjacent to the nanopore. The electrode can be a non-sacrificial electrode. A lipid bilayer can be formed over the plurality of wells using a bubble.
    Type: Application
    Filed: June 19, 2023
    Publication date: December 28, 2023
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Randall W. Davis, Edward Shian Liu, Eric Takeshi Harada, Anne Aguirre, Andrew Trans, James Pollard, Cynthia Cech
  • Patent number: 11846281
    Abstract: A delivery system for a sensor chip includes a plurality of selectable ports and a two-way pump port selectively connectable to each of the selectable ports. The two-way pump port is configured to allow material to be drawn or delivered from or to the two-way pump port. The delivery system also includes a chamber and a bypass waste channel that is selectively connectable to the two-way pump port. The plurality of selectable ports includes a selectable chamber port connected to the chamber and the chamber has a chamber waste exit. Material may selectively flow through the chamber to a waste collection via the chamber waste exit or flow to the waste collection via the bypass waste channel that bypasses the chamber waste exit.
    Type: Grant
    Filed: November 12, 2020
    Date of Patent: December 19, 2023
    Assignee: Roche Sequencing Solutions, Inc.
    Inventor: Robert A Yuan